Peptides and Cachexia: Wasting Syndrome Research
Research overview of peptides investigated for cachexia and wasting syndrome, including IGF-1 LR3 and Sermorelin, with citations and a plain-English summary.
Research overview of peptides investigated for cachexia and wasting syndrome, including IGF-1 LR3 and Sermorelin, with citations and a plain-English summary.
What Is GDF-8 (Myostatin)? Growth Differentiation Factor 8 (GDF-8), more commonly known as myostatin, is a secreted protein belonging to the transforming growth factor beta (TGF-β) superfamily.
What Is Melanotan I? Melanotan I (MT-I), also known by its pharmaceutical name afamelanotide and the brand name Scenesse, is a synthetic linear analog of alpha-melanocyte-stimulating hormone (alpha-MSH).
What Is Thymulin? Thymulin, formerly designated as FTS (Facteur Thymique Sérique, or Serum Thymic Factor), is a nonapeptide composed of nine amino acids with the sequence pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn.
Semaglutide and liraglutide are both GLP-1 receptor agonists used in diabetes and obesity research. But they differ significantly in potency, half-life, dosing frequency, and clinical outcomes. Here is the full comparison.
Muscle wasting — whether from illness, injury, inactivity, or aging — is driven by an imbalance between muscle protein synthesis and breakdown. Research peptides like IGF-1 LR3 and MGF are studied for their anti-catabolic and anabolic effects.
Sarcopenia — the progressive loss of muscle mass with age — affects more than 10% of adults over 60. Research peptides like IGF-1 LR3 and Follistatin are being studied for their roles in preserving and rebuilding lean mass.
Cagrilintide and Tirzepatide are two distinct approaches to metabolic and weight loss research. One targets amylin receptors; the other activates GIP and GLP-1. Here is what the data shows when you compare them.
Myofascial pain syndrome involves painful trigger points in muscle and fascia. Research peptides including BPC-157, TB-500, and GHK-Cu are studied for their roles in connective tissue repair and pain reduction.
Chronic pain syndrome involves persistent pain lasting more than three months across multiple body systems. Research peptides like BPC-157 and TB-500 are studied for their potential roles in reducing underlying pain drivers.